✦ LIBER ✦

Cost-effectiveness of rivaroxaban versus warfarin anticoagulation for the prevention of recurrent venous thromboembolism: A U.S. perspective

✍ Scribed by Seaman, Craig D.; Smith, Kenneth J.; Ragni, Margaret V.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Analysis of Extended

✍ Coleman, Craig I.; Limone, Brendan L.; Bookhart, Brahim K.; Mody, Samir H.; Nute 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 441 KB

Dalteparin versus Warfarin for the Preve

✍ Dranitsaris, George; Vincent, Mark; Crowther, Mark 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 132 KB

Low-Molecular-Weight Heparin versus Warf

✍ S.K. Das; A.T. Cohen; R.A. Edmondson; E. Melissari; V.V. Kakkar 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 226 KB

PCV43 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV49 COST-EFFECTIVENESS ANALYSIS OF RIV

✍ P. Vorobyev; L. Krasnova; O. Borisenko; D. Lukyantseva; E. Bashlakova 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

CV3 COST-EFFECTIVENESS OF RIVAROXABAN VE

✍ Chen, XB; Wang, CY; Eggington, S; Zhu, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB